1505 studies found for:    Open Studies | "Virus Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza
Condition: Virus Diseases
Interventions: Drug: Danirixin 15 mg FBE;   Drug: Danirixin 50 mg FBE;   Drug: Placebo;   Drug: Oseltamivir 75 mg
22 Recruiting A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: MEDI8897;   Drug: Placebo
23 Recruiting An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV Infection
Condition: Hepatitis C Virus
Intervention:
24 Recruiting A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV Vaccine (GSK3003891A) formulation 1;   Biological: RSV Vaccine (GSK3003891A) formulation 2;   Biological: RSV Vaccine (GSK3003891A) formulation 3;   Drug: Placebo (Formulation buffer S9b)
25 Not yet recruiting Partnership for Research on Ebola VACcinations
Condition: Ebola Virus Disease
Interventions: Biological: Ad26.ZEBOV;   Biological: MVA-BN-Filo;   Biological: rVSVΔG-ZEBOV-GP;   Biological: Placebo;   Biological: rVSV boost
26 Recruiting ZIKA Vaccine in Naive Subjects
Condition: Zika Virus Infection
Interventions: Drug: Saline;   Biological: Zika Virus Purified Inactivated Vaccine (ZPIV)
27 Recruiting Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine
Condition: Respiratory Syncytial Viral Infections
Interventions: Biological: SynGEM;   Other: placebo
28 Recruiting Clinical Trial of Efficacy of Anaferon for Children® in the Treatment of Influenza and Acute Respiratory Viral Infections in Children
Condition: Influenza and Acute Respiratory Viral Infections
Interventions: Drug: Anaferon for children;   Drug: Placebo
29 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
Intervention:
30 Recruiting BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients
Condition: BK Virus (BKV) Viremia
Intervention:
31 Recruiting Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine
Condition: Chikungunya Virus Infection
Interventions: Biological: MV-CHIK low dose;   Biological: MV-CHIK high dose;   Biological: Priorix®;   Biological: physiological saline solution
32 Recruiting Safety and Immunogenicity of the RSV D46cpΔM2-2 Vaccine in RSV-Seropositive Children and RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: D46cpΔM2-2 vaccine;   Biological: Placebo
33 Recruiting A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV F vaccine with adjuvant;   Biological: Formulation buffer
34 Recruiting Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)
Conditions: Zika Virus;   Dengue Virus;   Chikungunya Virus Infections
Intervention:
35 Recruiting Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy
Condition: Hepatitis C Virus Infection
Interventions: Drug: LDV/SOF;   Drug: Placebo
36 Recruiting Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen
Condition: Ebola Virus Survivor
Intervention: Drug: Favipiravir
37 Not yet recruiting Zika-Vaccine Dose Finding Study Regarding Safety, Immunogenicity and Tolerability
Condition: Zika Virus
Interventions: Biological: MV-ZIKA;   Other: Placebo
38 Recruiting Allogeneic Virus-specific T Cell Lines (VSTs)
Condition: Viral Infections After HSCT
Intervention: Biological: VSTs
39 Recruiting Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India
Condition: Hepatitis C Virus
Intervention: Drug: SOF
40 Recruiting Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China
Condition: Viral Infection
Intervention: Biological: CMV/EBV specific CTLs

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.